3billion to Join Genomic Technologies Conference on Orphan Diseases in Kazakhstan
- Event | 25. 09. 18

3billion is pleased to announce our participation in the upcoming conference “Genomic Technologies for Diagnostics and Treatment of Orphan Diseases in Kazakhstan”, which will take place on September 25–26, 2025, at Rahat Palace, Almaty, Kazakhstan.
Programs
As part of the scientific program, our colleagues will deliver the following sessions on September 25:
📌 Progress in Rare Disease Diagnostics: Genetic Testing from 3billion
👨💼 Minsoo Kim, Sales Manager, Global Business, 3billion, Inc.
📌 Clinical Exome/Genome Sequencing in 60,000 Patients with Rare Genetic Disorders
👩⚕️ Dr. Gohun Seo, Chief Medical Officer, 3billion, Inc.


In addition, distinguished local experts from Kazakhstan will present their research on September 26:
📌 Genetic Diagnosis of Rare Neurological Syndromes in Children
👩⚕️ Dr. Bakhytkul Myrzaliyeva, Senior Lecturer, Department of Neurology, Kazakhstan-Russian Medical University (Almaty, Kazakhstan)
📌 Exome Sequencing in Clinical Practice: From Deep Phenotyping to Diagnosis
👩⚕️ Dr. Nigara Khalmakhammetovna Yerkhojayeva, Neurologist & PhD Doctoral Student, Khoja Akhmet Yassawi International Kazakh-Turkish University (Turkestan, Kazakhstan)


3billion is honored to contribute to this important event, joining with leading Kazakhstani clinicians and researchers to advance rare disease diagnostics and genomic medicine in the region.
We look forward to connecting with the medical community in Almaty and sharing how genomic testing is transforming patient care.
Do you find this post helpful?
Click the button below to copy and share the link.

3billion Inc.
3billion is dedicated to creating a world where patients with rare diseases are not neglected in diagnosis and treatment.